Brittany Simone, DO
Radiation Oncology · Philadelphia, PANPI 1295146777
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $350 of the $474 with a category attached, or 73.8%. Teleflex LLC accounts for 73.8% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $383, more than ten times the $17 reported in 2020. That places this record below the midpoint for radiation oncology clinicians in PA, where the typical reported total is $405.
Across 7 payments — averaging $67.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$350
- AstraZeneca$33
- Merck$24
- Myriad Genetic Laboratories, Inc.$18
- Tactile Systems Technology Inc$17
- Novocure Inc.$17
- plus $16 from 1 others
What the payments were for
- Speaking & faculty fees$35074%
- Food & beverage$12426%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 1 | $350 |
| AstraZeneca | 1 | $33 |
| Merck | 1 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $17 |
| Novocure Inc. | 1 | $17 |
| Varian Medical Systems, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barrigel$350
How this compares
$474 in reported general payments places this provider in the 50th percentile of 339 radiation oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Philadelphia
- Neil TaunkPhiladelphia$203K
- Wenyin ShiPhiladelphia$119K
- Kevin NeadPhiladelphia$50K
- Adam DickerPhiladelphia$46K
- Tinatin ChabrashviliPhiladelphia$39K
- Bryan PukenasPhiladelphia$36K
- Sameera KumarPhiladelphia$29K
- Joshua MeyerPhiladelphia$25K
- Abigail BermanPhiladelphia$25K
- Michelle Alonso-BasantaPhiladelphia$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.